Back
ESC Professional Premium Access

PRADA II: Sacubitril-Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy

Session: Late-Breaking Clinical Science: heart and vasculature in cardio-oncology
Topic: Cardio-Oncology
Speaker: Professor T. Omland (Nordbyhagen, NO)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Torbjorn Omland

Akershus University Hospital - AHUS, Nordbyhagen (Norway)
10 presentations
4 followers

5 more presentations in this session

Incidence, risk-factors & prognosticators of ICI-myocarditis in the French population

Speaker: Professor J. Salem (Paris, FR)

Access
Slides
Video
Like
Thumbnail

Menopause modulates vascular toxicity of docetaxel

Speaker: Doctor P. Szczepaniak (Cracow, PL)

Access
Slides
Video
Like
Thumbnail

EMPATICC: Optimized Heart Failure Therapy in Terminal Cancer to Improve Self Care Ability

Speaker: Doctor M. Anker (Berlin, DE)

Access
Slides
Video
Like
Thumbnail

Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity

Speaker: Professor J. Salem (Paris, FR)

Access
Slides
Video
Like
Thumbnail

NT-proBNP Guide

Speaker: Professor B. Ky (Philadelphia, US)

Access
Slides
Video
Like
Thumbnail

Access the full session

Late-Breaking Clinical Science: heart and vasculature in cardio-oncology

Speakers: Professor T. Omland, Professor J. Salem, Doctor P. Szczepaniak, Doctor M. Anker, Professor J. Salem...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources